InvestorsHub Logo

berthabluefish1

08/31/18 11:32 AM

#13035 RE: Tim501 #13032

Hoping they say by adding Cytosorb early to cart t cell they can really cut down CRS.Maybe they can even up the dose and get better results without CRS by adding Cytosorb.IMO This would be huge news for us and pps would take off.JMO

clints

08/31/18 11:58 AM

#13036 RE: Tim501 #13032

It hit $13.40 on August 3rd and closed at $11.625 the same day and CTSO reported the amendment on August 3rd. EXPLANATORY NOTE



CytoSorbents Corporation has prepared this Amendment No. 1 (this “Amendment No. 1”) to its Registration Statement on Form S-3, filed with the Securities and Exchange Commission (the “SEC”) on July 26, 2018 (the “Registration Statement”), solely to incorporate by reference its Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 2, 2018. No other change is made to the prospectus constituting Part I of the Registration Statement or Part II of the Registration Statement.



This registration statement contains two prospectuses:


· a base prospectus, which covers the offering, issuance and sale by us of up to $150,000,000 in the aggregate of the securities identified above from time to time in one or more offerings; and


· a sales agreement prospectus covering the offering, issuance and sale by us of up to a maximum aggregate offering price of $25,000,000 of our common stock that may be issued and sold under that certain Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co., dated November 4, 2015 (as amended by that certain Amendment No. 1 to Sales Agreement, dated as of July 26, 2018, the “Sales Agreement”).